Health Evaluation of Abilify Long-term Therapy

Summary

This is a post-market surveillance, and the treatment to patients will be depended upon the decision based on physician's clinical judgment. The health profiles during the switching period, after 12 weeks short-term use, and after 52 weeks long-term use of aripiprazole will be recorded and evaluated.

Timeline

Start

2006-08

Primary completion

2009-04

Completion

2009-04

Drugs

Indications